| John M Gorup, MD | |
|
1345 Unity Place, Suite 310, Lafayette, IN 47905-5769 | |
| (765) 446-5215 | |
| (765) 446-5211 |
| Full Name | John M Gorup |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 33 Years |
| Location | 1345 Unity Place, Lafayette, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215906029 | NPI | - | NPPES |
| 200029859 | Other | IN | RAILROAD MEDICARE |
| 200146050 | Medicaid | IN | |
| 000000110519 | Other | IN | ANTHEM PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 01046921A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Franciscan Health Lafayette | Lafayette, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Indiana Spine Group, Pc | 4082502349 | 37 |
News Archive
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology.
Researchers have developed a new scoring system that may better identify adolescents with the metabolic syndrome, a group at increased risk of later developing Type 2 diabetes and heart disease.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
› Verified 2 days ago
| Entity Name | Indiana Spine Group, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609960046 PECOS PAC ID: 4082502349 Enrollment ID: O20040308001261 |
News Archive
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology.
Researchers have developed a new scoring system that may better identify adolescents with the metabolic syndrome, a group at increased risk of later developing Type 2 diabetes and heart disease.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John M Gorup, MD Po Box 4699, Lafayette, IN 47903-4699 Ph: (765) 449-2732 | John M Gorup, MD 1345 Unity Place, Suite 310, Lafayette, IN 47905-5769 Ph: (765) 446-5215 |
News Archive
A bacteria which infects people with cystic fibrosis could help combat other antibiotic-resistant microbes, according to a team from Cardiff and Warwick Universities.
A non-pathogenic bacterium is capable to trigger an autoimmune disease similar to the multiple sclerosis in the mouse, the model animal which helps to explain how human diseases work. This is what a group of researchers from the Catholic University of Rome, led by Francesco Ria (Institute of General Pathology) and Giovanni Delogu (Institute of Microbiology), have explained for the first time in a recently published article on the Journal of Immunology.
Researchers have developed a new scoring system that may better identify adolescents with the metabolic syndrome, a group at increased risk of later developing Type 2 diabetes and heart disease.
Celldex Therapeutics, Inc. today announced preliminary results from the Company's randomized Phase 2b EMERGE study of CDX-011 (glembatumumab vedotin) antibody drug conjugate in patients with glycoprotein NMB (GPNMB) expressing, advanced, heavily pretreated breast cancer. Preliminary results suggest that CDX-011 induces impressive response rates compared to current, available therapies in patients with advanced, refractory breast cancers with high GPNMB expression.
A team of researchers led by Kath Bogie, DPhil (PhD), a biomedical engineer and associate professor of orthopaedics and biomedical engineering at Case Western Reserve University School of Medicine, and colleagues from Case Western Reserve and other institutions, has received a $1.8M, three-year grant from the U.S. Department of Defense to develop an implantable muscle stimulator for preventing pressure ulcers and deep tissue injuries to the buttocks.
› Verified 2 days ago
Dr. Mark Christopher Page, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 S Creasy Ln, Suite 120, Lafayette, IN 47905 Phone: 765-447-4165 Fax: 765-447-4168 | |
Laurette Chang, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2600 Ferry St, Lafayette, IN 47904 Phone: 765-448-8335 Fax: 765-448-7656 | |
Eric Marcus Orenstein, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2600 Ferry St, Lafayette, IN 47904 Phone: 765-448-8000 Fax: 765-448-7613 | |
Dr. Michael Edgar Highhouse, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 S Creasy Ln, Suite 120, Lafayette, IN 47905 Phone: 765-447-4165 Fax: 765-447-6978 | |
John T Bauman, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 S Creasy Ln, Suite 120, Lafayette, IN 47905 Phone: 765-447-4165 Fax: 765-447-4168 | |
Dr. Joel Andrew Virkler, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1411 S Creasy Ln, Suite 120, Lafayette, IN 47905 Phone: 765-447-4165 Fax: 765-447-4168 |